Known targets — ChEMBL curated mechanism
ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO
The experimentally established mechanism targets of Phosphonic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphonic Acid SCHEMBL11044913 | 1.00 | — | — | |
| Phosphonic Acid SCHEMBL28360410 | 1.00 | — | — | |
| Phosphonic Acid SCHEMBL29523497 | 1.00 | — | — | |
| Phosphonic Acid SCHEMBL30849604 | 1.00 | — | — | |
| Phosphonic Acid SCHEMBL25330767 | 0.94 | — | — | |
| Phosphonic Acid SCHEMBL11113988 | 0.94 | — | — | |
| Phosphonic Acid SCHEMBL6549011 | 0.94 | — | — | |
| Phosphonic Acid SCHEMBL21874589 | 0.94 | — | — | |
| Phosphonic Acid SCHEMBL5468942 | 0.94 | — | — | |
| Phosphonic Acid SCHEMBL3273642 | 0.94 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 286 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116832728-A | Yellow phosphorus phosphoric acid circulating purification treatment device and use method | 贵州福泉川东化工有限公司 | 2023-10-03 | — | — | CN | claimed |
| CN-214611551-U | Production system of hydrated phosphoric acid | 襄阳高隆磷化工有限责任公司 | 2021-11-05 | — | — | CN | claimed |
| CN-102341448-B | Radiation-absorbing material | CHEM FAB BUDENHEIM KG | 2013-11-06 | — | — | CN | claimed |
| CN-102341448-A | RADIATION-ABSORBING MATERIAL | BUDENHEIM KG CHEM FAB | 2012-02-01 | — | — | CN | claimed |
| JP-11079753-A | — | — | None | — | — | JP | disclosed |
| JP-11263875-A | — | — | None | — | — | JP | disclosed |
| US-12637492-B2 | Peptide inhibitors of focal adhesion kinase activity and uses thereof | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2026-05-26 | — | — | US | disclosed |
| US-20260041669-A1 | SOLID FORMS OF A CDK INHIBITOR | RELAY THERAPEUTICS INC (US) | 2026-02-12 | — | — | US | disclosed |
| US-20260021095-A1 | BIFUNCTIONAL COMPOUNDS CONTAINING PYRIDO[2,3-d]PYRIMIDIN-7(8H)-ONE DERIVATIVES FOR DEGRADING CYCLIN-DEPENDENT KINASE 2 VIA UBIQUITIN PROTEASOME PATHWAY | NIKANG THERAPEUTICS INC (US) | 2026-01-22 | — | — | US | disclosed |
| US-12521386-B2 | Small molecule inhibitors of the androgen receptor activity and/or expression and uses thereof | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2026-01-13 | — | — | US | disclosed |
| US-12509468-B2 | Quindoline compounds and uses thereof | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2025-12-30 | — | — | US | disclosed |
| US-20250367193-A1 | BIFUNCTIONAL COMPOUNDS CONTAINING SUBSTITUTED PYRIMIDINE DERIVATIVES FOR DEGRADING CYCLIN-DEPENDENT KINASE 2 VIA UBIQUITIN PROTEASOME PATHWAY | NIKANG THERAPEUTICS INC (DE) | 2025-12-04 | — | — | US | disclosed |
| EP-1348718-A1 | EPOXIDIZED THERMOPLASTIC POLYMERS AND PROCESSES FOR THEIR PRODUCTION | DAICEL CHEMICAL INDUSTRIES, Ltd. (JP) | 2003-10-01 | — | — | EP | disclosed |
| US-20030139533-A1 | Epoxidized thermoplastic polymers and processes for their production | DAICEL CHEMICAL INDUSTRIES, (JP) | 2003-07-24 | — | — | US | disclosed |
| JP-H11263875-A | STABILIZER COMPOSITION, COMPOSITION COMPRISING THE SAME AND CHLORINE-CONTAINING POLYMER, AND STABILIZATION METHOD FOR CHLORINE-CONTAINING POLYMER | WITCO VINYL ADDITIVES GMBH | 1999-09-28 | — | — | JP | disclosed |
| JP-H1179753-A | PRODUCTION OF PHOSPHATE GLASS | ASAHI GLASS CO LTD | 1999-03-23 | — | — | JP | disclosed |
| US-4554144-A | Removal of magnesium and/or aluminum values from impure aqueous phosphoric acid | OCCIDENTAL RESEARCH CORPORATION (US) | 1985-11-19 | — | — | US | disclosed |
| EP-0144420-A1 | GUANIDATED AMINOPHOSPHONIC ACID COMPOUNDS. | KENOGARD AB (SE) | 1985-06-19 | — | — | EP | disclosed |
| WO-1985000038-A1 | GUANIDATED AMINOPHOSPHONIC ACID COMPOUNDS | KENOGARD AB (SE) | 1985-01-03 | — | — | WO | disclosed |
| US-4112118-A | FROM PHOSPHORIC ACID, WATER, AND A BASE | ALBRIGHT & WILSON LTD. (GB) | 1978-09-05 | — | — | US | disclosed |